Page last updated: 2024-08-17

cycloheximide and Autosomal Dominant Juvenile Parkinson Disease

cycloheximide has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Greene, LA; Jackson-Lewis, V; Jin, ZH; Malagelada, C; Przedborski, S	1
Dawson, TM; Dawson, VL; Moore, DJ; Zhang, L	1

Other Studies

2 other study(ies) available for cycloheximide and Autosomal Dominant Juvenile Parkinson Disease

Article	Year
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-20, Volume: 30, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cell Death; Cycloheximide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Serine; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Transfection; Tyrosine 3-Monooxygenase	2010
A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. Journal of neurochemistry, 2003, Volume: 87, Issue:6 Topics: Autoantigens; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cycloheximide; Electrophoresis, Gel, Pulsed-Field; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Leucine; Methionine; Mutation, Missense; Oncogene Proteins; Parkinsonian Disorders; Phenylalanine; Precipitin Tests; Protein Deglycase DJ-1; Protein Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins c-myc; Ribonucleoproteins; RNA, Messenger; SS-B Antigen; Sulfur Isotopes; Transfection	2003

Article

Year

Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-20, Volume: 30, Issue:3

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cell Death; Cycloheximide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Serine; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Transfection; Tyrosine 3-Monooxygenase

2010

A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization.

Journal of neurochemistry, 2003, Volume: 87, Issue:6

Topics: Autoantigens; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cycloheximide; Electrophoresis, Gel, Pulsed-Field; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Leucine; Methionine; Mutation, Missense; Oncogene Proteins; Parkinsonian Disorders; Phenylalanine; Precipitin Tests; Protein Deglycase DJ-1; Protein Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins c-myc; Ribonucleoproteins; RNA, Messenger; SS-B Antigen; Sulfur Isotopes; Transfection

2003